COMPLEMENT INHIBITORS
- avacopan (TAVNEOS)
- danicopan (VOYDEYA)
- eculizumab (SOLIRIS)
- iptacopan (iptacopan hydrochloride) (FABHALTA)
- pegcetacoplan (EMPAVELI)
- ravulizumab (ULTOMIRIS)
- zilucoplan (zilucoplan sodium) (ZILBRYSQ)
Using Health Canada Drug Database
updated on 14Sep2025.